Cite
HARVARD Citation
Gandhi, L. et al. (2017). Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria. European journal of cancer. pp. 27-33. [Online].